Literature DB >> 3731183

Biosynthesis of disialylated beta-D-galactopyranosyl-(1----3)-2-acetamido-2-deoxy-beta-D-glucopy ran osyl oligosaccharide chains. Identification of a beta-D-galactoside alpha-(2----3)- and a 2-acetamido-2-deoxy-beta-D-glucoside alpha-(2----6)-sialyltransferase in regenerating rat liver and other tissues.

H T de Heij, P L Koppen, D H van den Eijnden.   

Abstract

Regenerating rat liver microsomes contain a beta-D-galactoside alpha-(2----3)- and a 2-acetamido-2-deoxy-beta-D-glucoside alpha-(2----6)-sialyltransferase that are involved in the synthesis of the terminal alpha-NeuAc-(2----3)-beta-D-Galp-(1----3)-alpha-[NeuAc-(2----6)]-beta- D-GlcpNAc-(1----R) group occurring in human milk oligosaccharides and the glycan chains of several N-glycoproteins. Analysis by liquid chromatography and methylation of the products of sialylation obtained when lacto-N-tetraose [beta-D-Galp-(1----3)-beta-D-GlcpNAc-(1----3)-beta-D-Galp-(1----4) -D-Glc] was used as a substrate in the incubations in vitro indicated that the disialylated sequence is formed for greater than 95% through the tetrasaccharide alpha-NeuAc-(2----3)-beta-D-Gal-(1----3)-beta-D-GlcNAc-(1----3)-beta-D-G al- (1----4)-D-Glc as one of two possible intermediates. This indicates that in the synthesis of the disialylated sequence the alpha-(2----3)- and the alpha-(2----6)-sialyltransferase act in a highly preferred order in which the alpha-(2----3) enzyme acts first. This order is imposed by the specificity of the alpha-(2----6)-sialyltransferase, which requires an alpha-NeuAc-(2----3)-beta-D-Gal-(1----3)-beta-D-GlcNAc-(1----R) sequence for optimal activity, and shows very low and no activity with beta-D-Gal-(1----3)-beta-D-GlcNAc-(1----R) and beta-D-GlcNAc-(1----R) acceptor structures, respectively. Results obtained with normal rat, fetal calf, rabbit and human liver, and human placenta indicated that very similar or identical sialyltransferases occur in these tissues. It is suggested that these enzymes differ from the sialyltransferases that previously had been identified in fetal calf liver and human placenta.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731183     DOI: 10.1016/s0008-6215(00)90371-9

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  Synthetic disialyl hexasaccharides protect neonatal rats from necrotizing enterocolitis.

Authors:  Hai Yu; Kam Lau; Vireak Thon; Chloe A Autran; Evelyn Jantscher-Krenn; Mengyang Xue; Yanhong Li; Go Sugiarto; Jingyao Qu; Shengmao Mu; Li Ding; Lars Bode; Xi Chen
Journal:  Angew Chem Int Ed Engl       Date:  2014-05-21       Impact factor: 15.336

2.  Knockout of mouse beta 1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins.

Authors:  N Kotani; M Asano; Y Iwakura; S Takasaki
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

3.  Native and sialic acid masked Lewis(a) antigen reactivity in medullary thyroid carcinoma. Distinct tumour-associated and prognostic relevant antigens.

Authors:  M Vierbuchen; S Schröder; A Larena; G Uhlenbruck; R Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Acute phase inflammation is characterized by rapid changes in plasma/peritoneal fluid N-glycosylation in mice.

Authors:  Yoann Rombouts; Hulda S Jónasdóttir; Agnes L Hipgrave Ederveen; Karli R Reiding; Bas C Jansen; Jona Freysdottir; Ingibjörg Hardardottir; Andreea Ioan-Facsinay; Martin Giera; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2016-02-29       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.